OtherClinical Investigations (Human)
Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study
W. Phillip Law, William Y.S. Wang, Peter T. Moore, Peter N. Mollee and Arnold C.T. Ng
Journal of Nuclear Medicine June 2016, jnumed.115.169870; DOI: https://doi.org/10.2967/jnumed.115.169870
W. Phillip Law
Princess Alexandra Hospital, Australia
William Y.S. Wang
Princess Alexandra Hospital, Australia
Peter T. Moore
Princess Alexandra Hospital, Australia
Peter N. Mollee
Princess Alexandra Hospital, Australia
Arnold C.T. Ng
Princess Alexandra Hospital, Australia
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study
W. Phillip Law, William Y.S. Wang, Peter T. Moore, Peter N. Mollee, Arnold C.T. Ng
Journal of Nuclear Medicine Jun 2016, jnumed.115.169870; DOI: 10.2967/jnumed.115.169870
Jump to section
Related Articles
Cited By...
- Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future
- Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
- Novel Tracers for the Imaging of Cardiac Amyloidosis
- Novel Tracers for the Imaging of Cardiac Amyloidosis
- 18F-Florbetaben and PET/CT Holds Promise for the Identification and Differentiation Among Cardiac Amyloidosis Entities
- [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions
- Molecular Imaging of Cardiac Amyloidosis
- Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
- Myocardial Amyloidosis: The Exemplar Interstitial Disease
- Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy